…FDA’s biosimilars lead Leah Christl said last week at DIA’s annual conference in Chicago that she expects interchangeable biosimilars will come to market within the next two years, though possibly sooner.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”